Stephen P Squinto's Net Worth
$63.3 Million
Who is Stephen P Squinto?
Stephen P Squinto has an estimated net worth of $63.3 Million. This is based on reported shares across multiple companies, which include SpringWorks Therapeutics, Inc., Compass Therapeutics, Inc., Passage BIO, Inc., Chemomab Therapeutics Ltd., Audentes Therapeutics, Inc., and ALEXION PHARMACEUTICALS INC.
SEC CIK
Stephen P Squinto's CIK is 0001231954
Past Insider Trading and Trends
2013 was Stephen P Squinto's most active year for acquiring shares with 16 total transactions. Stephen P Squinto's most active month to acquire stocks was the month of January. 2004 was Stephen P Squinto's most active year for disposing of shares, totalling 47 transactions. Stephen P Squinto's most active month to dispose stocks was the month of April. 2014 saw Stephen P Squinto paying a total of $11,487,388.84 for 111,059 shares, this is the most they've acquired in one year. In 2013 Stephen P Squinto cashed out on 379,848 shares for a total of $28,635,958.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SpringWorks Therapeutics, Inc. (SWTX) Snapshot price: $38.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.80% | 4.82K |
—
|
—
| 131.65K |
May 19
| |||
Form 4
| +0.88% | 1.11K |
—
|
—
| 126.83K |
May 20
| |||
Form 4
| -13.39% | -19.43K |
$76.19 | -$1,480,521.83 | 125.73K |
Scheduled
|
Apr 27 - Apr 28
| ||
Form 4
| -1.07% | -1.57K |
$75.04 | -$117,655.04 | 145.16K |
Scheduled
|
Apr 14 - Apr 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
∞
| 7.41M |
$18.00 |
—
| 7.41M |
Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29 - Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Compass Therapeutics, Inc. (CMPX) Snapshot price: $1.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Passage BIO, Inc. (PASG) Snapshot price: $0.7
Head Research and Dev
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Chemomab Therapeutics Ltd. (CMMB) Snapshot price: $1.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Audentes Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |